133 related articles for article (PubMed ID: 18280336)
21. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study.
Farshi S; Mansouri P; Safar F; Khiabanloo SR
Int J Dermatol; 2010 Oct; 49(10):1188-93. PubMed ID: 20883409
[TBL] [Abstract][Full Text] [Related]
22. Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Leonardi CL; Papp KA; Gordon KB; Menter A; Feldman SR; Caro I; Walicke PA; Compton PG; Gottlieb AB;
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):425-33. PubMed ID: 15761420
[TBL] [Abstract][Full Text] [Related]
23. Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study.
Strober BE; Menon K; McMichael A; Hordinsky M; Krueger G; Panko J; Siu K; Lustgarten JL; Ross EK; Shapiro J
Arch Dermatol; 2009 Nov; 145(11):1262-6. PubMed ID: 19917955
[TBL] [Abstract][Full Text] [Related]
24. An uncontrolled, open label study of sulfasalazine in severe alopecia areata.
Aghaei S
Indian J Dermatol Venereol Leprol; 2008; 74(6):611-3. PubMed ID: 19171984
[TBL] [Abstract][Full Text] [Related]
25. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
Unal M
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of alopecia areata: modern principles and perspectives].
Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
[TBL] [Abstract][Full Text] [Related]
27. Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients.
Brunasso AM; Salvini C; Massone C
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):415-9. PubMed ID: 19207662
[TBL] [Abstract][Full Text] [Related]
28. Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
Papp KA; Miller B; Gordon KB; Caro I; Kwon P; Compton PG; Leonardi CL;
J Am Acad Dermatol; 2006 Apr; 54(4 Suppl 1):S164-70. PubMed ID: 16488338
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Trink A; Sorbellini E; Bezzola P; Rodella L; Rezzani R; Ramot Y; Rinaldi F
Br J Dermatol; 2013 Sep; 169(3):690-4. PubMed ID: 23607773
[TBL] [Abstract][Full Text] [Related]
30. Alopecia areata treated with efalizumab: a case with significant hair re-growth after long-term therapy.
Smith JR; Akin RS; Wells MJ
J Drugs Dermatol; 2009 Aug; 8(8):758-60. PubMed ID: 19663114
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata.
Anuset D; Perceau G; Bernard P; Reguiai Z
Dermatology; 2016; 232(2):242-8. PubMed ID: 26735937
[TBL] [Abstract][Full Text] [Related]
32. Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study.
Olsen EA; Kornacki D; Sun K; Hordinsky MK
J Am Acad Dermatol; 2020 Feb; 82(2):412-419. PubMed ID: 31622643
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of efalizumab using safe psoriasis control.
Papp KA; Henninger E
BMC Dermatol; 2006 Sep; 6():8. PubMed ID: 16984639
[TBL] [Abstract][Full Text] [Related]
34. High-dose steroid pulse therapy for the treatment of severe alopecia areata.
Tsai YM; Chen W; Hsu ML; Lin TK
J Formos Med Assoc; 2002 Mar; 101(3):223-6. PubMed ID: 12051021
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of oral mega pulse methylprednisolone for severe therapy resistant Alopecia areata.
Bin Saif GA; Al-Khawajah MM; Al-Otaibi HM; Al-Roujayee AS; Alzolibani AA; Kalantan HA; Al-Sheikh OA; Arafah MM
Saudi Med J; 2012 Mar; 33(3):284-91. PubMed ID: 22426909
[TBL] [Abstract][Full Text] [Related]
36. Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study.
Zaher H; Gawdat HI; Hegazy RA; Hassan M
Dermatology; 2015; 230(4):308-13. PubMed ID: 25765294
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety.
Lai VWY; Chen G; Gin D; Sinclair R
J Am Acad Dermatol; 2019 Sep; 81(3):694-701. PubMed ID: 31048013
[TBL] [Abstract][Full Text] [Related]
38. ILK Index and Regrowth in Alopecia Areata.
Stallings AM; Velez MW; Fiessinger LA; Piliang MP; Mesinkovska NA; Kyei A; Bergfeld WF
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):47-9. PubMed ID: 26551947
[TBL] [Abstract][Full Text] [Related]
39. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
Sasmaz S; Arican O
Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
[TBL] [Abstract][Full Text] [Related]
40. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
